Last year, the FDA has issued several safety warnings regarding the opiod skin patch Fentanyl.




Now, for full safety measure, Actavis (the distributor of Fentanyl Skin Patch) has recalled the remaining Fentanyl skin patch in the U.S.

Actavis Inc., the United States manufacturing and marketing division of the international generic pharmaceutical company Actavis Group hf, today announced that its subsidiary Actavis South Atlantic LLC is proceeding with the voluntarily recall from wholesalers and pharmacies of all lots of Fentanyl transdermal system CII patches sold in the United States.

Find more details from the FDA News.